MUMBAI, India, July 31 -- Intellectual Property India has published a patent application (202521005184 A) filed by Indoco Remedies Limited on January 22, 2025, for Tablet In Tablet Composition.
Inventors include Panandikar Aditi; Inamdar Kavita; Jog Sunil; Wawde Gopal; and Pramod Korde.
The application for the patent was published on July 24, 2026, under issue no. 30/2026.
Abstract: The present invention relates to a pharmaceutical composition comprising Alogliptin or its pharmaceutically acceptable salt thereof, Metformin or its pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The present invention relates to a pharmaceutical composition comprising Alogliptin or its pharmaceutically acceptable salt thereof, Metformin or its pharmaceutically acceptable salt thereof and one or pharmaceutically acceptable excipients, wherein formulation is biphasic tablet. In one aspect, the present invention relates to a pharmaceutical composition comprising Alogliptin or its pharmaceutically acceptable salt thereof, Metformin or its pharmaceutically acceptable salt thereof and one or pharmaceutically acceptable excipients, wherein formulation is tablet in tablet. The present invention relates to pharmaceutical composition comprising Alogliptin or its pharmaceutically acceptable salt thereof, Metformin or its pharmaceutically acceptable salt thereof and one or pharmaceutically acceptable excipients, wherein the composition is used for the treatment of diabetes.
Disclaimer: Curated by HT Syndication.
